Powered by 
Translate
Translate
April 15, 2012
Contact: Gary Tilden,Chairman
Ingen Technologies, Inc
3410 La Sierra Avenue,Suite F507
Riverside, CA 92503
Phone: (951) 678-7840
INGEN APPROVES PLAN OF REORGANIZATION
Riverside, CA, April 15,2012- Ingen Technologies, Inc. (Pink Sheets: IGNT.PK), has submitted a Plan of Reorganization on the OTC Market - Supplemental Information. The company is currently evaluating several acquisition partners as a part of the plan. The management is preparing to file and bring current the financial reports for the periods between March 1, 2011 to March 31, 2012. These reports will be filed before May 1, 2012. The Plan of Reorganization was approved by the Board of Directors and the majority of shareholders votes.
"The company is focused on executing our Plan of Reorganization and moving in a direction of becoming a fully reporting company by the end of this year. There is value in our medical product line and intellectual property that will help the company grow over the next few years and compliment the best interests of our shareholders." Stated Gary Tilden, Chairman.
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
